Resveratrol regulation of PI3K-AKT signaling pathway genes in MDA-MB-231 breast cancer cells

Cancer Genomics and Proteomics

Volumn 3, Issue 6, 2006, Pages 383-388

  Rachid, Ousama ^a   Alkhalaf, Moussa ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

c fos; Cancer prevention; Microarray; p70S6K; PI3K pathway; Predictive cancer markers; Resveratrol

Indexed keywords

CASPASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN C FOS; PROTEIN KINASE B; RESVERATROL; S6 KINASE;

ARTICLE; BREAST CANCER; CANCER CELL; CHEMOLUMINESCENCE; CHEMOPROPHYLAXIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA MICROARRAY; DNA PROBE; DRUG MECHANISM; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE TARGETING; HUMAN; HUMAN CELL; MUTATION; NUCLEOTIDE SEQUENCE; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

VITACEAE;

EID: 33845970575     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Jeanet P, Bessis R and Gautheron B. The production of resveratrol (3,5,4′-trihydroxystilbene) by grape berries in different stages. Am J Enol Viticul 42: 41-46, 1991.
2. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW et al: Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275: 218-220, 1997.
3. Soleas GJ, Diamandis EP and Goldberg DM: The world of resveratrol. Adv Exp Med Biol 492: 159-182, 2001.
4. Pezzuto JM: Resveratrol: a whiff that induces a biologically specific tsunami. Cancer Biol Ther 3: 889-890, 2004.
5. Bhat KP and Pezzuto JM: Cancer chemopreventive activity of resveratrol. Ann N Y Acad Sci 957: 210-229, 2002.
6. Pervaiz S: Chemotherapeutic potential of the chemopreventive phytoalexin resveratrol. Drug Resist Updat 7: 333-344, 2004.
7. Chow AW, Murillo G, Yu C, van Breemen RB, Boddie AW, Pezzuto JM et al: Resveratrol inhibits rhabdomyosarcoma cell proliferation. Eur J Cancer Prev 14: 351-356, 2005.
8. She QB, Bode AM, Ma WY, Chen NY and Dong Z: Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Res 61: 1604-1610, 2001.
9. Schneider Y, Duranton B, Gosse F, Schleiffer R, Seiler N and Raul F: Resveratrol inhibits intestinal tumorigenesis and modulates host-defense-related gene expression in an animal model of human familial adenomatous polyposis. Nutr Cancer 39: 102-107, 2001.
10. Ahmad N, Adhami VM, Afaq F, Feyes DK and Mukhtar H: Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. Clin Cancer Res 7: 1466-1473, 2001.
11. Joe AK, Liu H, Suzui M, Vural ME, Xiao D and Weinstein IB: Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin Cancer Res 8: 893-903, 2002.
12. Chan TO, Rittenhouse SE and Tsichlis PN: AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide- dependent phosphorylation. Annu Rev Biochem 68: 965-1014, 1999.
13. Li HL, Wang AB, Huang Y, Liu DP, Wei C, Williams GM et al: Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways. Free Radic Biol Med 38: 243-257, 2005.
14. Haider UG, Roos TU, Kontaridis MI, Neel BG, Sorescu D, Griendling KK et al: Resveratrol inhibits angiotensin II- and epidermal growth factor-mediated Akt activation: role of Gab1 and Shp2. Mol Pharmacol 68: 41-48, 2005.
15. Pozo-Guisado E, Lorenzo-Benayas MJ and Fernandez-Salguero PM: Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor alpha-dependent mechanism: relevance in cell proliferation. Int J Cancer 109: 167-173, 2004.
16. Alkhalaf M: Resveratrol-induced growth inhibition in MDA-MB-231 breast cancer cells is associated with MAPK signaling and protein translation. Eur J Cancer Prev, in press, 2006.
17. Narayanan BA, Narayanan NK, Re GG and Nixon DW: Differential expression of genes induced by resveratrol in LNCaP cells: P53-mediated molecular targets. Int J Cancer 104: 204-212, 2003.
18. Yang SH, Kirn JS, Oh TJ, Kim MS, Lee SW, Woo SK et al: Genome-scale analysis of resveratrol-induced gene expression profile in human ovarian cancer cells using a cDNA microarray. Int J Oncol 22: 741-750, 2003.
19. Rodrigue CM, Porteu F, Navarro N, Bruyneel E, Bracke M, Romeo PH et al: The cancer chemopreventive agent resveratrol induces tensin, a cell-matrix adhesion protein with signaling and antitumor activities. Oncogene 24: 3274-3284, 2005.
20. Phelps M, Darley M, Primrose JN and Blaydes JP: p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells. Cancer Res 63: 2616-2623, 2003.
21. El-Mowafy AM and Alkhalaf M: Resveratrol activates adenylyl-cyclase in human breast cancer cells: a novel, estrogen receptor-independent cytostatic mechanism. Carcinogenesis 24: 869-873, 2003.
22. Cantley LC: The phosphoinositide 3-kinase pathway. Science 296: 1655-1657, 2002.
23. Srivastava R, Ratheesh A, Gude RK, Rao KV, Panda D and Subrahmanyam G: Resveratrol inhibits type II phosphatidylinositol 4-kinase: a key component in pathways of phosphoinositide turnover. Biochem Pharmacol 70: 1048-1055, 2005.
24. Poolman TM, Ng LL, Farmer PB and Manson MM: Inhibition of the respiratory burst by resveratrol in human monocytes: correlation with inhibition of PI3K signaling. Free Radic Biol Med 39: 118-132, 2005.
25. Lawlor MA, Mora A, Ashby PR, Williams MR, Murray-Tail V, Malone L et al: Essential role of PDK1 in regulating cell size and development in mice. EMBO J 21: 3728-3738, 2002.
26. Fernandes-Alnemri T, Litwack G and Alnemri ES: CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J Biol Chem 269: 30761-30764, 1994.
27. Shimizu T, Nakazato T, Xian MJ, Sagawa M, Ikeda Y and Kizaki M: Resveratrol induces apoptosis of human malignant B cells by activation of caspase-3 and p38 MAP kinase pathways. Biochem Pharmacol 71: 742-750, 2006.
28. Pozo-Guisado E, Merino JM, Mulero-Navarro S, Lorenzo-Benayas MJ, Centeno F, Alvarez-Barrientos A and Salguero PM: Resveratrol-induced apoptosis in MCF-7 human breast cancer cells involves a caspase-independent mechanism with down-regulation of Bcl-2 and NF-kappaB. Int J Cancer 115: 74-84, 2005.
29. Wolter F, Turchanowa L and Stein J: Resveratrol-induced modification of polyamine metabolism is accompanied by induction of c-Fos. Carcinogenesis 24: 469-474, 2003.
30. Franza BR, Rauscher FJ, Josephs SF and Curran T: The Fos complex and Fos-related antigens recognize sequence elements that contain AP-1 binding sites. Science 239: 1150-1153, 1988.
31. Treisman R: Journey to the surface of the cell: Fos regulation and the SRE. EMBO J 14: 4905-4913, 1995.
32. Hiromura M, Okada F, Obata T, Auguin D, Shibata T, Roumestand C and Noguchi M: Inhibition of Akt kinase activity by a peptide spanning the betaA strand of the protooncogene TCL1. J Biol Chem 279: 53407-53418, 2004.